$63.61
-6.61-9.41%
最終更新: Oct 16, 5:58 PM
$64.85
-5.37-7.65%
Benzinga
Benzinga
Benzinga
日曜日, 10 18
Benzinga
© 2026 Benzinga | All Rights Reserved
GeneDx Holdings (WGS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GeneDx Holdings (WGS) は、8 3, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$475M - $490Mの範囲と予想しています。
以前のガイダンスと比較して、GeneDx Holdingsは売上高予測を以前の範囲である維持から$475M - $490Mに引き上げました。
GeneDx Holdingsは、18から3 14, 2023の間に8 3, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 9 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.03 | $0.12 | $0.37 |
| Actual | $0.01 | $-0.28 | $0.14 | $0.49 |
| Surprise | +105.3% | -833.3% | +16.7% | +32.4% |
| Revenue | ||||
| Estimate | $110.7M | $112.1M | $119.9M | $104.3M |
| Actual | $114.4M | $102.3M | $121.0M | $116.7M |
| Surprise | +3.33% | -8.71% | +0.87% | +11.9% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.32 | $0.10 | $0.25 |
| Revenue | ||||
| Consensus | $122.8M | $142.0M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $0.01 | $-0.19 | 105.3 % |
| Q1 | May 4, 2026 | $-0.28 | $-0.03 | -833.3 % |
| Q4 | Feb 23, 2026 | $0.14 | $0.12 | 16.7 % |
| Q3 | Oct 28, 2025 | $0.49 | $0.37 | 32.4 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 3, 2026 | $114.44M | $110.75M | 3.33 % |
| Q1 | May 4, 2026 | $102.30M | $112.06M | -8.71 % |
| Q4 | Feb 23, 2026 | $120.99M | $119.94M | 0.87 % |
| Q3 | Oct 28, 2025 | $116.74M | $104.32M | 11.9 % |